Physician

Abishek R Rizal, M.D

According to 2025 Medicare claims, Abishek Rizal, M.D (NPI: 1518132067) practices psychiatry in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is JASON KELLOGG M.D. INC (NPI: 1235391624; TIN: 203153475) and primary practice location at 92647-7102.

Rizal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 461 traditional Medicare patients, billed 3,252 HCPCS/CPT codes, and received $251,329 in Medicare payments. The top billing code was 90792 (Psychiatric diagnostic evaluation with medical services). Part D data shows 359 prescription claims across 74 beneficiaries totaling $25,600 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 2 records totaling $243. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $30,446 to $251,329. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $94,523 and ending at $25,600. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$126K$251K2015 Medicare payment: $30,446 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $5,444 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $4,328 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $71,430 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $203,545 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $121,983 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $203,268 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $250,352 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $251,329 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015210627$30,446
201636151$5,444
201760146$4,328
2018N/RN/RN/R
2019212919$71,430
20203682,769$203,545
20212641,667$121,983
20223862,787$203,268
20234723,334$250,352
20244613,252$251,329

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$59K$118K2015 Drug cost: $94,523 (USD; Tot_Drug_Cst)2016 Drug cost: $8,605 (USD; Tot_Drug_Cst)2017 Drug cost: $28,089 (USD; Tot_Drug_Cst)2018 Drug cost: $118,204 (USD; Tot_Drug_Cst)2019 Drug cost: $8,624 (USD; Tot_Drug_Cst)2020 Drug cost: $45,937 (USD; Tot_Drug_Cst)2021 Drug cost: $46,583 (USD; Tot_Drug_Cst)2022 Drug cost: $15,311 (USD; Tot_Drug_Cst)2023 Drug cost: $12,962 (USD; Tot_Drug_Cst)2024 Drug cost: $25,600 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151251,474$94,523
201640160$8,605
201746387$28,089
20181001,041$118,204
201983345$8,624
202079388$45,937
202149164$46,583
202245238$15,311
202366284$12,962
202474359$25,600

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
90792Psychiatric diagnostic evaluation with medical services241260$136
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes112121$124
99238Hospital discharge day management, 30 minutes or less167191$66
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes3252,211$64
99308Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, 20 minutes or more4887$46

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EliquisApixaban21294$6,269
Divalproex SodiumDivalproex Sodium16432$825
RisperidoneRisperidone39984$701
Quetiapine FumarateQuetiapine Fumarate461,207$522
MirtazapineMirtazapine15383$409

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$243Janssen Pharmaceuticals, Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Abishek R. Rizal, M.D?

Tedicare shows public-source Medicare data for Abishek R. Rizal, M.D (NPI 1518132067), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abishek R. Rizal, M.D have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abishek R. Rizal, M.D?

Abishek R. Rizal, M.D is linked to JASON KELLOGG M.D. INC (billing NPI 1235391624) in the available physician profile data.

Does Abishek R. Rizal, M.D have Open Payments data?

Abishek R. Rizal, M.D has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.